Evaluation – 20220607 CSCC 2022 Symposium 2 Session Title: Evidence Based Laboratory Medicine, Personalized Laboratory Medicine and Direct to Consumer Testing Presenters: Dr. Chad Bousman, Department of Medical Genetics, University of Calgary Canada Dr. Kristin Hauff, University of British Columbia, Canada. Lead of Special Chemistry Prof. AE Zemlin, Head of Division of Chemical Pathology, Chair of IFCC Committee for Evidence-based Laboratory Medicine (C-EBLM) Objectives: At the conclusion of this session, participants will be able to: Recognize the science behind PM must be evidence based by reconciling the role of EBLM and PM in the laboratory. Appreciate that PM and DTC are not restricted to genetic testing Appreciate the advisory role of laboratory professionals toward clinicians and patients regarding PM and DTC laboratory testing 1. Please rate the Sessions overall by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly AgreeSufficient time was allowed for audience participation/active learning. One Two Three Four Five The facilities were satisfactory. One Two Three Four Five The session was free from commercial bias. One Two Three Four Five Overall, I would rate this Symposium as excellent. One Two Three Four Five 2. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Clinical pharmacogenetics as a tool to facilitate personalized/precision medicine - Dr. Chad Bousman, Department of Medical Genetics, University of Calgary Canada Objectives: At the end of the session, the participants will be able to: Identify different pharmacogenetic testing implementation approaches. Assess the strengths and weaknesses of pharmacogenetic tests. Recognize patient care situations that could benefit from pharmacogenetic testing. Clarity of Voice One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five Comments3. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Direct to Consumer Testing: where is the evidence? - Dr. Kristin Hauff, University of British Columbia, Canada. Lead of Special Chemistry Objectives: At the end of the session, the participants will be able to: Define direct to consumer testing in the context of Evidence Based Laboratory Medicine Identify major factors driving the direct to consumer testing Compare benefits and risks of direct to consumer testing Formulate a plan to manage direct to consumer testing in your organizations Clarity of Voice One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five Comments4. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Reconciling evidence-based laboratory medicine and precision medicine - Prof. AE Zemlin, Head of Division of Chemical Pathology, Chair of IFCC Committee for Evidence-based Laboratory Medicine (C-EBLM) Objectives: At the end of the session, the participants will be able to: Understand the concepts of evidence-based laboratory medicine (EBLM) and personalized medicine (PM) Appreciate the lack of evidence and need for more evidence in PM and how this can be addressed Appreciate how PM and EBLM may be used to decide on best personalized treatment options Formulate a plan to manage direct to consumer testing in your organizations Clarity of Voice One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five Comments4. As a result of attending this session, I am planning to: (please check one)a) Discuss the session with my colleagues Yes No b) Pursue additional learning activities. Yes No c) Complete a Personal Learning Project. Yes No d) Not change my practice. Yes No 3) Change my practice. Yes No 5. Please explain the change you are planning to make or the learning you plan to complete:6. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply) Medical Expert Communicator Collaborator Manager Health Advocate Scholar Professional 7. General comments about individual speakers8. What topics need to be addressed at future conferences to keep you up to date in your profession?Name Session Title Date Year Location Conference/Event CreditsEmail Session Code
